Who Paid My Doc
Joseph Mayer
Clinical Neurophysiology Blue Island, IL Medical Doctor
NPI 1316901234 CMS profile 542344
2320 High St, Blue Island, IL 60406
General payments
$303
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Joseph Mayer of Blue Island, IL is reported in the CMS Open Payments database as having received $303 across 7 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 25th percentile of Clinical Neurophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $53 | 2 | |
| 2022 | General | $236 | 4 | |
| 2021 | General | $14 | 1 |
Beside peers
- Joseph Mayer
- Clinical Neurophysiology median
- Middle half of Clinical Neurophysiology
- National median
In program year 2025, general payments to Joseph Mayer were reported at $0. Among 259 Clinical Neurophysiology profiles paid that year, the median was $435 and the middle half received between $121 and $1,917.
Show as a table
| Year | Joseph Mayer | Clinical Neurophysiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $306 | $88–$1,636 | $163 |
| 2020 | $0 | $299 | $85–$1,847 | $114 |
| 2021 | $14 | $325 | $96–$2,308 | $132 |
| 2022 | $236 | $395 | $106–$1,957 | $149 |
| 2023 | $53 | $388 | $120–$1,718 | $160 |
| 2024 | $0 | $471 | $137–$1,931 | $164 |
| 2025 | $0 | $435 | $121–$1,917 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 17 drugsPart D claims
592
Drug cost
$16,160
Branded share of claims
17.4%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | Brand | 65 | $2,921 | |
| Levetiracetam | Generic | 67 | $1,783 | |
| Gabapentin | Generic | 66 | $1,690 | |
| Divalproex Sodium Er Divalproex Sodium | Brand | 11 | $1,183 | |
| Oxcarbazepine | Generic | 17 | $1,174 | |
| Propranolol Hcl Er Propranolol Hcl | Brand | 27 | $1,090 | |
| Primidone | Generic | 40 | $930 | |
| Pyridostigmine Bromide | Generic | 18 | $919 | |
| Donepezil Hcl | Generic | 76 | $889 | |
| Memantine Hcl | Generic | 40 | $882 |
The 10 drugs with the highest cost, of 17 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,891 Part D prescribers listed as Neuropsychiatry; they describe a distribution and say nothing about conduct.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Neurophysiology in Illinois
Micheal MacKen
Clinical Neurophysiology · Chicago, IL
Sumayyah Abumurad
Clinical Neurophysiology · Chicago, IL
Abdallah Hamdallah
Clinical Neurophysiology · Palos Heights, IL
Akash Patel
Clinical Neurophysiology · Chicago, IL
Clarissa Liew
Clinical Neurophysiology · Champaign, IL
Zeina Rabi
Clinical Neurophysiology · Hinsdale, IL
Related records
Clinical Neurophysiology in Illinois
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Neurophysiology
Everyone recorded under this specialty, nationwide.
Doctors in Illinois
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.